Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000898432-09-000265
Filing Date
2009-03-02
Accepted
2009-03-02 17:06:23
Documents
1
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.INVESTMENT 10, L.L.C.

Document Format Files

Seq Description Document Type Size
1 sc-13g.htm SC 13G 325627
  Complete submission text file 0000898432-09-000265.txt   327781
Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611
Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

EIN.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address 3 N DUNLAP 3RD FLOOR VAN VIEEN BLDG MEMPHIS TN 38163
Business Address 3 NORTH DUNLAP AVE 3RD FL VAN VLEET BUILDING MEMPHIS TN 38163 901-523-9700
GTX INC /DE/ (Subject) CIK: 0001260990 (see all company filings)

EIN.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-79588 | Film No.: 09648464
SIC: 2834 Pharmaceutical Preparations